Annual CFO:
-$395.89M+$18.44M(+4.45%)Summary
- As of today, CYTK annual cash from operations is -$395.89 million, with the most recent change of +$18.44 million (+4.45%) on December 31, 2024.
- During the last 3 years, CYTK annual cash from operations has fallen by -$253.37 million (-177.77%).
- CYTK annual cash from operations is now -1170.49% below its all-time high of $36.98 million, reached on December 31, 2016.
Performance
CYTK Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$128.24M+$3.38M(+2.57%)Summary
- As of today, CYTK quarterly cash from operations is -$128.24 million, with the most recent change of +$3.38 million (+2.57%) on June 30, 2025.
- Over the past year, CYTK quarterly cash from operations has dropped by -$28.92 million (-29.12%).
- CYTK quarterly cash from operations is now -264.77% below its all-time high of $77.83 million, reached on December 31, 2016.
Performance
CYTK Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$426.92M-$28.92M(-7.27%)Summary
- As of today, CYTK TTM cash from operations is -$426.92 million, with the most recent change of -$28.92 million (-7.27%) on June 30, 2025.
- Over the past year, CYTK TTM cash from operations has dropped by -$27.86 million (-6.98%).
- CYTK TTM cash from operations is now -1254.41% below its all-time high of $36.98 million, reached on December 31, 2016.
Performance
CYTK TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CYTK Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +4.5% | -29.1% | -7.0% |
| 3Y3 Years | -177.8% | -41.7% | -110.1% |
| 5Y5 Years | -335.5% | -367.4% | -585.7% |
CYTK Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -177.8% | +4.5% | -95.6% | +2.6% | -73.5% | +2.6% |
| 5Y | 5-Year | -4526.8% | +4.5% | -345.9% | +2.6% | -4566.2% | +2.6% |
| All-Time | All-Time | -1170.5% | +4.5% | -264.8% | +2.6% | -1254.4% | +2.6% |
CYTK Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$128.24M(+2.6%) | -$426.92M(-7.3%) |
| Mar 2025 | - | -$131.62M(-100.7%) | -$398.00M(-0.5%) |
| Dec 2024 | -$395.89M(+4.5%) | -$65.57M(+35.4%) | -$395.89M(+2.1%) |
| Sep 2024 | - | -$101.50M(-2.2%) | -$404.36M(-1.3%) |
| Jun 2024 | - | -$99.31M(+23.3%) | -$399.06M(+5.3%) |
| Mar 2024 | - | -$129.51M(-74.9%) | -$421.55M(-1.7%) |
| Dec 2023 | -$414.33M(-38.3%) | -$74.04M(+23.0%) | -$414.33M(+5.5%) |
| Sep 2023 | - | -$96.20M(+21.0%) | -$438.49M(-3.4%) |
| Jun 2023 | - | -$121.81M(+0.4%) | -$423.91M(-8.0%) |
| Mar 2023 | - | -$122.29M(-24.5%) | -$392.58M(-31.1%) |
| Dec 2022 | -$299.52M(-110.2%) | -$98.19M(-20.3%) | -$299.52M(-21.7%) |
| Sep 2022 | - | -$81.63M(+9.8%) | -$246.06M(-21.1%) |
| Jun 2022 | - | -$90.47M(-209.6%) | -$203.20M(-42.9%) |
| Mar 2022 | - | -$29.22M(+34.7%) | -$142.22M(+0.2%) |
| Dec 2021 | -$142.52M(-1693.7%) | -$44.74M(-15.4%) | -$142.52M(-212.3%) |
| Sep 2021 | - | -$38.77M(-31.4%) | -$45.63M(-708.3%) |
| Jun 2021 | - | -$29.50M(+0.1%) | $7.50M(-21.5%) |
| Mar 2021 | - | -$29.52M(-156.6%) | $9.56M(+6.9%) |
| Dec 2020 | $8.94M(+109.8%) | $52.15M(+263.0%) | $8.94M(+114.4%) |
| Sep 2020 | - | $14.37M(+152.4%) | -$62.26M(+35.7%) |
| Jun 2020 | - | -$27.44M(+8.9%) | -$96.90M(-2.9%) |
| Mar 2020 | - | -$30.14M(-58.1%) | -$94.14M(-3.6%) |
| Dec 2019 | -$90.91M(+10.2%) | -$19.05M(+6.0%) | -$90.91M(-8.0%) |
| Sep 2019 | - | -$20.27M(+17.9%) | -$84.18M(+12.4%) |
| Jun 2019 | - | -$24.68M(+8.3%) | -$96.15M(+2.2%) |
| Mar 2019 | - | -$26.91M(-118.3%) | -$98.31M(+2.9%) |
| Dec 2018 | -$101.22M(+0.5%) | -$12.33M(+61.8%) | -$101.22M(+10.4%) |
| Sep 2018 | - | -$32.23M(-20.1%) | -$112.96M(-6.4%) |
| Jun 2018 | - | -$26.85M(+9.9%) | -$106.21M(+4.0%) |
| Mar 2018 | - | -$29.81M(-23.8%) | -$110.62M(-8.7%) |
| Dec 2017 | -$101.76M(-375.2%) | -$24.07M(+5.5%) | -$101.76M(>-9900.0%) |
| Sep 2017 | - | -$25.48M(+18.5%) | $141.00K(-99.0%) |
| Jun 2017 | - | -$31.26M(-49.3%) | $13.50M(-59.7%) |
| Mar 2017 | - | -$20.94M(-126.9%) | $33.55M(-9.3%) |
| Dec 2016 | $36.98M(+657.4%) | $77.83M(+742.0%) | $36.98M(+172.8%) |
| Sep 2016 | - | -$12.12M(-8.1%) | -$50.79M(-3.6%) |
| Jun 2016 | - | -$11.22M(+35.9%) | -$49.01M(-4.3%) |
| Mar 2016 | - | -$17.51M(-76.1%) | -$46.98M(-1062.2%) |
| Dec 2015 | $4.88M(+110.9%) | -$9.94M(+3.9%) | $4.88M(-27.1%) |
| Sep 2015 | - | -$10.35M(-12.6%) | $6.70M(-11.1%) |
| Jun 2015 | - | -$9.19M(-126.7%) | $7.53M(+2.6%) |
| Mar 2015 | - | $34.36M(+522.6%) | $7.34M(+116.4%) |
| Dec 2014 | -$44.84M | -$8.13M(+14.6%) | -$44.84M(+8.7%) |
| Sep 2014 | - | -$9.52M(-1.5%) | -$49.14M(-67.6%) |
| Jun 2014 | - | -$9.38M(+47.4%) | -$29.32M(-120.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$17.82M(-43.4%) | -$13.32M(-72.6%) |
| Dec 2013 | -$7.72M(+76.9%) | -$12.43M(-220.6%) | -$7.72M(-219.9%) |
| Sep 2013 | - | $10.31M(+55.6%) | -$2.41M(+88.8%) |
| Jun 2013 | - | $6.62M(+154.2%) | -$21.60M(+41.5%) |
| Mar 2013 | - | -$12.22M(-71.6%) | -$36.92M(-10.4%) |
| Dec 2012 | -$33.44M(+26.7%) | -$7.12M(+19.8%) | -$33.44M(+10.3%) |
| Sep 2012 | - | -$8.88M(-2.1%) | -$37.26M(+1.0%) |
| Jun 2012 | - | -$8.70M(+0.4%) | -$37.65M(+9.2%) |
| Mar 2012 | - | -$8.74M(+20.2%) | -$41.45M(+9.1%) |
| Dec 2011 | -$45.59M(-1.7%) | -$10.95M(-18.1%) | -$45.59M(-4.2%) |
| Sep 2011 | - | -$9.26M(+25.9%) | -$43.74M(+2.4%) |
| Jun 2011 | - | -$12.51M(+2.9%) | -$44.79M(+1.6%) |
| Mar 2011 | - | -$12.88M(-41.7%) | -$45.50M(-1.5%) |
| Dec 2010 | -$44.83M(-632.7%) | -$9.09M(+11.9%) | -$44.83M(-6.5%) |
| Sep 2010 | - | -$10.32M(+21.9%) | -$42.09M(+2.9%) |
| Jun 2010 | - | -$13.21M(-8.2%) | -$43.34M(-642.0%) |
| Mar 2010 | - | -$12.21M(-92.4%) | $8.00M(-5.0%) |
| Dec 2009 | $8.42M(+113.7%) | -$6.35M(+45.1%) | $8.42M(+398.0%) |
| Sep 2009 | - | -$11.57M(-130.3%) | $1.69M(+150.9%) |
| Jun 2009 | - | $38.12M(+423.4%) | -$3.32M(+94.4%) |
| Mar 2009 | - | -$11.79M(+9.8%) | -$59.29M(+3.3%) |
| Dec 2008 | -$61.33M(-1940.9%) | -$13.07M(+21.1%) | -$61.33M(+1.6%) |
| Sep 2008 | - | -$16.58M(+7.2%) | -$62.29M(-11.3%) |
| Jun 2008 | - | -$17.86M(-29.2%) | -$55.96M(-8.5%) |
| Mar 2008 | - | -$13.82M(+1.5%) | -$51.56M(-1615.7%) |
| Dec 2007 | -$3.00M(+93.6%) | -$14.04M(-37.0%) | -$3.00M(-40.5%) |
| Sep 2007 | - | -$10.25M(+23.8%) | -$2.14M(+39.8%) |
| Jun 2007 | - | -$13.45M(-138.7%) | -$3.55M(-144.8%) |
| Mar 2007 | - | $34.73M(+363.7%) | -$1.45M(+96.9%) |
| Dec 2006 | -$47.17M(-19.5%) | -$13.17M(-12.9%) | -$47.17M(-7.0%) |
| Sep 2006 | - | -$11.66M(-2.8%) | -$44.09M(-7.1%) |
| Jun 2006 | - | -$11.35M(-3.3%) | -$41.17M(+1.7%) |
| Mar 2006 | - | -$10.99M(-8.9%) | -$41.87M(-6.0%) |
| Dec 2005 | -$39.48M(-16.0%) | -$10.09M(-15.4%) | -$39.48M(+2.4%) |
| Sep 2005 | - | -$8.75M(+27.4%) | -$40.47M(+1.3%) |
| Jun 2005 | - | -$12.04M(-40.0%) | -$41.01M(-15.2%) |
| Mar 2005 | - | -$8.60M(+22.4%) | -$35.61M(-4.6%) |
| Dec 2004 | -$34.03M(-11.5%) | -$11.08M(-19.3%) | -$34.03M(-48.3%) |
| Sep 2004 | - | -$9.29M(-39.7%) | -$22.95M(-67.9%) |
| Jun 2004 | - | -$6.65M(+5.3%) | -$13.67M(-94.7%) |
| Mar 2004 | - | -$7.02M | -$7.02M |
| Dec 2003 | -$30.51M(-36.8%) | - | - |
| Dec 2002 | -$22.30M(-1152.3%) | - | - |
| Dec 2001 | -$1.78M(+84.3%) | - | - |
| Dec 2000 | -$11.37M | - | - |
FAQ
- What is Cytokinetics, Incorporated annual cash from operations?
- What is the all-time high annual cash from operations for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated annual cash from operations year-on-year change?
- What is Cytokinetics, Incorporated quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated quarterly cash from operations year-on-year change?
- What is Cytokinetics, Incorporated TTM cash from operations?
- What is the all-time high TTM cash from operations for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated TTM cash from operations year-on-year change?
What is Cytokinetics, Incorporated annual cash from operations?
The current annual cash from operations of CYTK is -$395.89M
What is the all-time high annual cash from operations for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high annual cash from operations is $36.98M
What is Cytokinetics, Incorporated annual cash from operations year-on-year change?
Over the past year, CYTK annual cash from operations has changed by +$18.44M (+4.45%)
What is Cytokinetics, Incorporated quarterly cash from operations?
The current quarterly cash from operations of CYTK is -$128.24M
What is the all-time high quarterly cash from operations for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high quarterly cash from operations is $77.83M
What is Cytokinetics, Incorporated quarterly cash from operations year-on-year change?
Over the past year, CYTK quarterly cash from operations has changed by -$28.92M (-29.12%)
What is Cytokinetics, Incorporated TTM cash from operations?
The current TTM cash from operations of CYTK is -$426.92M
What is the all-time high TTM cash from operations for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high TTM cash from operations is $36.98M
What is Cytokinetics, Incorporated TTM cash from operations year-on-year change?
Over the past year, CYTK TTM cash from operations has changed by -$27.86M (-6.98%)